| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/04/1995 | WO1995011701A1 Inhibition of hiv mucosal infection |
| 05/04/1995 | WO1995011693A1 Hemoregulatory peptides |
| 05/04/1995 | WO1995011676A1 Long-acting antifungal o/w preparation |
| 05/04/1995 | WO1995011670A1 Liposomal defensins |
| 05/04/1995 | WO1995003327A3 Peptides for neutralizing the toxicity of lipid a |
| 05/04/1995 | CA2175255A1 Retroviral superantigens, superantigen peptides, and methods of use |
| 05/04/1995 | CA2169453A1 Inhibition of hiv mucosal infection |
| 05/03/1995 | EP0650733A1 Live in ovo vaccine |
| 05/03/1995 | EP0650494A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof |
| 05/03/1995 | EP0650493A1 Hybrid oligonucleotide phosphorothioates |
| 05/03/1995 | EP0650489A1 Rapamycin derivatives |
| 05/03/1995 | EP0650488A1 Quinoline and naphthyridine prodrugs |
| 05/03/1995 | EP0650487A1 Novel diazabicycloalkenes and processes for the preparation thereof |
| 05/03/1995 | EP0650481A1 Pyrimidine compounds used in the therapy |
| 05/03/1995 | EP0650474A1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis |
| 05/03/1995 | EP0650371A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 05/03/1995 | EP0650369A1 Major histocompatibility complex antigens for use as vaccine against an immunodeficiency virus |
| 05/03/1995 | EP0650365A1 Biocidal composition containing mustard seed plant extract. |
| 05/03/1995 | EP0650363A1 Antiviral combinations |
| 05/03/1995 | EP0650362A1 Antiviral combinations |
| 05/03/1995 | EP0650357A1 Rapamycin derivatives |
| 05/03/1995 | EP0650356A1 Rapamycin derivatives |
| 05/03/1995 | EP0557336B1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-thion-1,1-dioxides as antiviral medicaments |
| 05/03/1995 | EP0504202B1 Improved meningococcal polysaccharide conjugate vaccine |
| 05/03/1995 | EP0470144B1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours |
| 05/03/1995 | EP0406398B1 Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
| 05/03/1995 | EP0379522B1 Uses of recombinant colony stimulating factor-1 |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 05/03/1995 | CN1102184A Novel pyridonecarboxylic acid derivatives and processes for preparing the same |
| 05/02/1995 | US5412104 Hypotensive and antiviral agents |
| 05/02/1995 | US5412089 Antitumor, antiviral |
| 05/02/1995 | US5411948 Use of host cell phospholipids for inhibiting microbial colonization |
| 05/02/1995 | US5411733 Antiviral agent containing crude drug |
| 05/02/1995 | CA1335429C Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor |
| 05/02/1995 | CA1335425C Antiviral or antibacterial compound and method of use |
| 04/29/1995 | CA2133620A1 Aminoquinoline derivatives |
| 04/27/1995 | WO1995011317A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/27/1995 | WO1995011310A1 Antifungal antibiotic cepacidine a |
| 04/27/1995 | WO1995011246A1 Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo[1,2,4]triazolo[1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation |
| 04/27/1995 | WO1995011231A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995011045A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | WO1995011036A1 Antiviral drug |
| 04/27/1995 | WO1995011028A1 Flavin derivatives as anti-viral agents |
| 04/27/1995 | WO1995011010A1 Methods and compositions for microencapsulation of antigens for use as vaccines |
| 04/27/1995 | WO1995010999A1 Novel composition |
| 04/27/1995 | WO1995007101A3 Living salmonella vaccine |
| 04/27/1995 | WO1994027594A3 Stable copper(i) complexes and methods related thereto |
| 04/27/1995 | CA2174552A1 Flavin derivatives as anti-viral agents |
| 04/27/1995 | CA2174532A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/27/1995 | CA2173972A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | CA2173468A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2171842A1 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
| 04/26/1995 | EP0649906A1 Nucleotide sequences coding for a protein with urease activity |
| 04/26/1995 | EP0649651A1 Soft gelatin capsule manufacture |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0649470A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 04/26/1995 | EP0649467A1 Self-stabilized oligonucleotides as therapeutic agents |
| 04/26/1995 | EP0649443A1 Oxazolone derived materials |
| 04/26/1995 | EP0649435A1 Membrane-associated immunogens of mycobacteria |
| 04/26/1995 | EP0649430A1 Derivatives of 16-membered ring antibiotic macrolides |
| 04/26/1995 | EP0649429A1 Heteroatomic oligonucleoside linkages |
| 04/26/1995 | EP0649413A1 Uracil derivatives as enzyme inhibitors |
| 04/26/1995 | EP0649304A1 Composition and methods for decreasing muscle breakdown |
| 04/26/1995 | EP0580782A4 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 04/26/1995 | EP0544746B1 Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 04/26/1995 | EP0482076B1 Stable vaccine compositions containing interleukins |
| 04/26/1995 | EP0451190B1 Deletion analogues of magainin peptides |
| 04/26/1995 | EP0436642B1 Pre-activated therapeutic agents derived from photoactive compounds |
| 04/26/1995 | EP0419513B1 Recombinant flagellin vaccines |
| 04/26/1995 | CN1101912A New cephem compounds |
| 04/25/1995 | US5410029 Fungicides; configuration |
| 04/25/1995 | US5409950 Anticholesterol, antilipemic agents and an enzyme squalene synthase inhibitors, fungicides |
| 04/25/1995 | US5409933 Antibiotics |
| 04/25/1995 | US5409927 Morpholin- and thiomorpholin-4-ylamides |
| 04/25/1995 | US5409920 2-(3-pyridyl)-carbapenem antibacterial agents |
| 04/25/1995 | US5409918 Crystalline cephem acid addition salts and process for their preparation |
| 04/25/1995 | US5409898 Synergistic composition containing beta-lactam antibiotic and cationic polypeptide |
| 04/25/1995 | CA1335368C Macrolide compounds and their preparation |
| 04/25/1995 | CA1335356C Therapeutic uses of 2',5'-oligoadenylates |
| 04/25/1995 | CA1335346C Method of treating erectile dysfunction |
| 04/20/1995 | WO1995010777A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | WO1995010625A1 Dna encoding 1,3-beta-d glucan synthase subunits |
| 04/20/1995 | WO1995010534A1 Polypeptide and anti-hiv agent prepared therefrom |
| 04/20/1995 | WO1995010531A1 Oligopeptides derived from c-reactive protein fragments |
| 04/20/1995 | WO1995010520A1 3-pyrrolidinylthio-carbapenem derivatives and their antimicrobal activity |
| 04/20/1995 | WO1995010519A1 Quinolizinone type compounds |
| 04/20/1995 | WO1995010300A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains and methods of making same |
| 04/20/1995 | WO1995010296A1 A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| 04/20/1995 | WO1995010285A1 The use of inositoltrisphosphate for the preparing of medicaments |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | WO1995010265A1 Therapeutic delivery compositions and methods of use thereof |
| 04/20/1995 | DE4403311C1 Process for the preparation of nevirapine (11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-d iazepin]-6-one) |
| 04/20/1995 | CA2178341A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | CA2173990A1 A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| 04/20/1995 | CA2173606A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof |
| 04/20/1995 | CA2173459A1 Quinolizinone type compounds |
| 04/20/1995 | CA2151283A1 Polypeptide and anti-hiv agent prepared therefrom |
| 04/19/1995 | EP0648501A1 Compositions comprising G-CSF for treating or preventing infections in canine and feline animals |
| 04/19/1995 | EP0648497A1 Emulsified preparation of aureobasidin |
| 04/19/1995 | EP0648490A2 Septicemia suppressing substitution fluid preparation |